| (Values in U.S. Thousands) | Jun, 2026 | Jun, 2026 | Jun, 2026 | Jun, 2026 | Jun, 2026 |
| Sales | 0 | 0 | 0 | 0 | 0 |
| Sales Growth | unch | unch | unch | unch | unch |
| Net Income | 0 | 0 | 0 | 0 | 0 |
| Net Income Growth | unch | unch | unch | unch | unch |
Hubei Minkang Pharm Ltd (HBMK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Hubei Minkang Pharmaceutical Ltd., formerly DGT Corp.is incorporated in Nevada on September 20,2007. It is a pharmaceutical company. The Company through its subsidiary, HBMK produces and markets Traditional Chinese Medicines ('TCM') and some chemical pharmaceuticals, which are able to be purchased Over-the-Counter ('OTC') and some by prescription only. The Company operates in seven production lines capable of producing 10 different product types including pills, tablets, capsules, granules, oral liquids, syrups, mixtures and injections, in more than 400 formulations and dosages.